+
Site Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

LEARN MORE:

Amplatzer LAA Occluder

Related Videos

Next generation Amulet LAAO X. Freixa

Landmark trials changing the Guidelines C. Skurk

Debate: Concomitant PFA & LAAO M. Gunawardene & T. Zeus

Clot or not K. Piayda

Leaks: To close or not to close?

Post-procedural pharma D. Arzamendi

Live Case K. Kaczmarek

Mitigating sub-optimal implants - strategies X. Freixa

TRENDING TOPICS

The Standard of Caring For TR

Nothing Evokes Safety Like TriClip

EACTS Symposium 2025

Learn from Leading Experts at the EACTS Symposium 2025

TAVI strategies for patient lifetime management

Explore index TAVI strategies for patient lifetime management

CONNEXT


HUB
RELATED RESOURCES

The Amulet IDE Trial

Amplatzer™ Amulet™ LAA Occluder

CONNEXT


LIVE
RELATED EVENTS

Next generation Amulet LAAO X. Freixa

Landmark trials changing the Guidelines C. Skurk

Debate: Concomitant PFA & LAAO M. Gunawardene & T. Zeus

Clot or not K. Piayda

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline